Considering these findings and our data, ZBTB7C may inhibit Myc and then inhibit tumor cell glutamine metabolism, resulting in a relative excess of glutamine in the microenvironment, promoting the proliferation of immune cells (especially mast cells and B cells), and ultimately inhibiting the proliferation of CRC cells to achieve a tumor suppressor effect. Here, MYC is linked to neoplasm.